Keiji Kojima, the new president of Hitachi, Ltd., who became the top management this month, responded to an interview with NHK and others, and will strengthen the medical field, such as cell and gene analysis, where global competition is intensifying with the new coronavirus. I clarified the policy to go.
Among them, President Kojima said that in recent years, the company has made a series of large-scale acquisitions of overseas electric power system business and IT companies. My mission is to lead to growth. I will use the technology of the acquired company to innovate various products of my company. "
On the other hand, he said, "I never dreamed that a new coronavirus vaccine could be produced so quickly. I think it is the cell industry that will grow significantly." With the new coronavirus as an opportunity, we have announced a policy to strengthen the medical field, where global competition is intensifying, and make it a pillar of profits.
In addition, President Kojima said, "Until now, China was positioned as the world's production factory, but from now on, India will be the source of digital resources in the world." And expressed the desire to secure human resources.